Armata Pharmaceuticals Inc 's Revenue in the fiscal year 2025 $ 4.90 millions
Armata Pharmaceuticals Inc 's Revenue in the fiscal year 2024 $ 5.17 millions
Armata Pharmaceuticals Inc 's Revenue in the fiscal year 2023 $ 4.53 millions
Armata Pharmaceuticals Inc 's Revenue in the fiscal year 2022 $ 5.51 millions
Armata Pharmaceuticals Inc 's Revenue in the fiscal year 2021 $ 4.47 millions
ARMP Revenue second quarter 2026 Y/Y Growth Comment
Armata Pharmaceuticals Inc reported Revenue increase of 15.67% year on year in the second quarter 2026, to $ 2.51 millions, this is lower than Armata Pharmaceuticals Inc 's recent average Revenue surge of 104.95%.
Looking into second quarter 2026 results within Biotechnology & Pharmaceuticals industry 31 other companies have achieved higher Revenue growth. While Armata Pharmaceuticals Inc ' s Revenue growth of 15.67% ranks overall at the positon no. 1255 in the second quarter 2026.
ARMP Revenue ( Y/Y Growth %)
2026
2025
2024
2023
4th Quarter
December
-
27.42 %
-18.95 %
45.71 %
3rd Quarter
September
-
-60.94 %
141.46 %
-8.21 %
2nd Quarter
June
15.67 %
-
-
-47.87 %
1st Quarter
March
-
-
21.25 %
-35.48 %
FY
-
-5.21 %
14.1 %
-
Financial Statements
Armata Pharmaceuticals Inc 's second quarter 2026 Revenue
Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026
Armata Pharmaceuticals Inc 's Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
1327.27 %
22.45 %
-100 %
(Jun 30 2013)
ARMP's II. Quarter Q/Q Revenue Comment
Armata Pharmaceuticals Inc achieved in the II. Quarter 2026 above company average sequential Revenue doubling of 217.72%, to $ 2.51 millions, from $0.79 millions in the first quarter. ARMP is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.
Within Biotechnology & Pharmaceuticals industry 4 other companies have achieved higher Revenue quarter on quarter growth. While Armata Pharmaceuticals Inc 's Revenue growth quarter on quarter, overall rank is 81.
Armata Pharmaceuticals Inc achieved in the II. Quarter 2026 above company average sequential Revenue doubling of 217.72%, to $ 2.51 millions, from $0.79 millions in the first quarter. ARMP is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.
Within Biotechnology & Pharmaceuticals industry 4 other companies have achieved higher Revenue quarter on quarter growth. While Armata Pharmaceuticals Inc 's Revenue growth quarter on quarter, overall rank is 81.
Armata Pharmaceuticals Inc 's 12 Months Revenue Growth Year on Year
Revenue TTM Growth
12 Months Ending (Jun 30 2026)
12 Months Ending (Mar 31 2026)
12 Months Ending (Dec 31 2025)
12 Months Ending (Sep 30 2025)
12 Months Ending (Jun 30 2025)
Cumulative Revenue 12 Months Ending
$ 6.03
$ 5.69
$ 0.00
$ 0.00
$ 0.00
Y / Y Revenue Growth (TTM)
-
-
-
-
-
Year on Year Revenue Growth Overall
Ranking
#
#
#
#
#
Seqeuential Revenue Change (TTM)
5.99 %
-
-
-
-
Seq. Revenue Growth (TTM) Overall
Ranking
# 1929
# 0
# 0
# 0
# 0
Cumulative Revenue growth Comment
Armata Pharmaceuticals Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 15.67% year on year, to $ 6 millions if the fiscal year would have ended in Jun 30 2026. Armata Pharmaceuticals Inc 's trailing twelve months Revenue growth was higher than company's average 0% and higher than % growth in Mar 31 2026. And, Armata Pharmaceuticals Inc realized the fastest Revenue growth, in Biotechnology & Pharmaceuticals industry. But from twelve months ended Mar 31 2026 rise was beneth at 5.99 % from $5.69 millions achieved in the period from Mar 31 2026 to Jun 30 2025. Still this was evidence of convincing trend, while the usual Q/Q TTM gain stands at -20.93%.
Armata Pharmaceuticals Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .
Armata Pharmaceuticals Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 15.67% year on year, to $ 6 millions if the fiscal year would have ended in Jun 30 2026. Armata Pharmaceuticals Inc 's trailing twelve months Revenue growth was higher than company's average 0% and higher than % growth in Mar 31 2026. And, Armata Pharmaceuticals Inc realized the fastest Revenue growth, in Biotechnology & Pharmaceuticals industry. But from twelve months ended Mar 31 2026 rise was beneth at 5.99 % from $5.69 millions achieved in the period from Mar 31 2026 to Jun 30 2025. Still this was evidence of convincing trend, while the usual Q/Q TTM gain stands at -20.93%. The momentum is even more impressive from twelve months ended Mar 31 2026 exhibited at 5.99 % increase from $5.69 millions in the period from Mar 31 2026 to Jun 30 2025.
Armata Pharmaceuticals Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .
About Armata Pharmaceuticals Inc Revenue Growth Rates (ARMP), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
27.15%